STOCK MARKET BSE NSE

Hyderabad-based TCS scientists find 31 potential compounds to treat COVID-19

They will be collaborating with Council for Scientific and Industrial Research laboratories for synthesising and testing these compounds to find the perfect drug.

Published: 27th March 2020 10:44 AM  |   Last Updated: 27th March 2020 02:24 PM   |  A+A-

vaccine

For representational purposes (File Photo)

Express News Service

HYDERABAD: As the world races to find a cure for COVID-19, scientists from Hyderabad-based Tata Consultancy Services Innovation Labs-Hyderabad (Life Sciences division), using Artificial Intelligence, found 31 new promising chemical compounds, which they claim can be synthesised and tested further to find perfect drug to fight the dreaded disease.  The pre-print research paper was prepared by four TCS scientists — Navneet Bung, Sowmya Ramaswamy, Gopalkrishnan Bulusu and Arijit Roy. They will be collaborating with Council for Scientific and Industrial Research laboratories for synthesising and testing these compounds to find the perfect drug.

Speaking to Express, Ananth Krishnan, Chief Technology Officer of TCS, said, “The TCS Life Sciences Research Area is engaged in cutting edge application oriented research in Synthetic Biology. De-novo drug candidate design is the first step in a long sequence of steps to find a cure to COVID-19. The collaboration between TCS and CSIR is a standing example of public private partnership in tackling a problem of national importance.”

A common way to treat COVID-19 that scientists across the world are looking at is to inhibit protease called chymotrypsin-like (3CL), an enzyme that is present in ‘Severe acute respiratory syndrome Coronavirus 2’ (SARS-CoV-2) which causes COVID-19 disease.

The 3CL protease plays an essential role in cleaving long polyproteins generated by the virus into various functional proteins which is necessary for it to replicate in the human body.  The TCS scientists used AI to design new chemical compounds that can help in inhibiting the protease.

A comparative analysis of the 31 new compounds revealed that they possessed protease inhibiting quality similar to compounds against COVID-19 that are presently under clinical trials. Scientists have also published the complete list of 31 new chemical compounds, so that anyone in the world can test them against SARS-CoV-2.

Stay up to date on all the latest Good News news with The New Indian Express App. Download now

Comments(1)

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

  • SHARATH AHUJA

    Kudos to the scientists for using AI to help in the search for potential candidates that could lead to the cure for COVID-19.
    4 months ago reply
flipboard facebook twitter whatsapp